Wenxin Zheng, M.D., Tenured Professor of Pathology, Obstetrics and Gynecology, American board certified pathologist, graduated from Shanghai Medical College Fudan University and trained at Columbia University, Cornell University, and Brown University Medical Centers in anatomic pathology and gynecologic pathology, Selected by US News and World Report multiple times as one of America's top pathologists, Dr. Zheng is an internationally recognized gynecologic pathologist with outstanding expertise in every aspect of gynecologic pathology.  Dr. Zheng’s main research contributions include endometrial serous carcinogenesis and precancerous lesion endometrial glandular dysplasia, cell origin of low-grade ovarian serous carcinoma, hormonal etiology of ovarian epithelial cancers, and tubal contribution of ovarian endometriosis and its associated ovarian cancers.  In addition to these, Dr. Zheng has created a novel approach called "One Stop Cervical Care (OSCC)" to diagnose and treat cervical precancers. 


Medical School
Shanghai Medical College of Fudan University (1982)
Hospital of Obstetrics and Gynecology (1983), Obstetrics & Gynecology
Hospital of Obstetrics and Gynecology (1986), Obstetrics & Gynecology
Columbia University Medical Center (1989), Molecular Reproduction
Cornell New York Presbyterian Hospital (1995), Pathology
Brown University Woman & Infant Hospital (1996), Gynecologic Pathology

Research Interest

  • Biomarkers to aid the diagnosis of gynecologic cancers
  • Cervical cancer: suitable model of cervical cancer screening, effective intervention, and prevention in developing countries.
  • Endometrial serous carcinoma: carcinogenesis, early detection and prevention
  • Ovarian cancer early detection and prevention
  • Tubal origin of ovarian endometriosis and its related cancer development
  • Tubal secretory cell biology


Featured Publications LegendFeatured Publications

Primary Ovarian Pregnancy: A Case Series and Analysis.
Wang Y, Chen H, Zhao M, Fadare O, Zheng W Int. J. Gynecol. Pathol. 2018 Jan
Female adnexal tumor of probable Wolffian origin (FATWO)
Elena Lucas and Wenxin Zheng Pathology Outlines 2018
Clear Cell Renal Cell Carcinoma Metastatic to the Gynecologic Tract: A Clinicopathologic Analysis of 17 Cases.
Fadare O, Desouki MM, Gwin K, Hanley KZ, Jarboe EA, Liang SX, Quick CM, Rawish KR, Roma AA, Zheng W, Hecht JL, Parkash V, Osunkoya AO Int. J. Gynecol. Pathol. 2017 Nov
The Significance of L1CAM Expression in Clear Cell Carcinoma of the Endometrium.
Fadare O, Roma AA, Desouki MM, Gwin K, Hanley KZ, Jarboe EA, Liang SX, Quick CM, Zheng W, Hecht JL, Parkash V, Wang XJ Histopathology 2017 Sep
Does a p53 "Wild-type" Immunophenotype Exclude a Diagnosis of Endometrial Serous Carcinoma?
Fadare O, Roma AA, Parkash V, Zheng W, Walavalkar V Adv Anat Pathol 2017 Sep
Pathological findings in explanted vaginal mesh.
Li L, Wang X, Park JY, Chen H, Wang Y, Zheng W Hum. Pathol. 2017 Sep
Gene expression profiles of ovarian low-grade serous carcinoma resemble those of fallopian tube epithelium.
Qiu C, Lu N, Wang X, Zhang Q, Yuan C, Yan S, Dongol S, Li Y, Sun X, Sun C, Zhang Z, Zheng W, Kong B Gynecol. Oncol. 2017 Sep
Malignant Female Adnexal Tumor of Probable Wolffian Origin: Case Report and Literature Review.
Hong S, Cui J, Li L, Buscema J, Liggins C, Zheng W Int. J. Gynecol. Pathol. 2017 Jul
Endometrial Carcinoma With Trophoblastic Components: Clinicopathologic Analysis of a Rare Entity.
Rawish KR, Buza N, Zheng W, Fadare O Int. J. Gynecol. Pathol. 2017 Jun
BRCA1 expression, proliferative and apoptotic activities in ovarian epithelial inclusions.
Wang Y, Wang Y, Wei L, Hong S, Zhao M, Zhang X, Zheng W J Ovarian Res 2017 Mar 10 1 12


Featured Books Legend Featured Books